Literature DB >> 3611684

The "epigastric distress syndrome". A possible disease entity identified by history and endoscopy in patients with nonulcer dyspepsia.

O Nyrén, H O Adami, S Gustavsson, P G Lindgren, L Lööf, A Nyberg.   

Abstract

Nonucler dyspepsia lacks a clear definition, and probably conceals several entities under this heading. It seems appropriate to deal separately with symptoms likely to be elicited from the upper digestive tract. Therefore, we propose "epigastric distress syndrome" (EDS) as a designation for chronic or recurrent epigastric pain without any anatomical antecedents and without concomitant symptoms consistent with established criteria of the irritable bowel syndrome. In this study 185 dyspeptic patients with a tentative diagnosis of EDS, based on symptoms and negative upper endoscopy, underwent laboratory screening, peroral cholecystograms, ultrasound scanning of the liver, biliary tract, and pancreas, biopsies from the distal part of the duodenum, and acid secretory tests. There were very few pathological findings. Five patients had gallstones. No single case of chronic pancreatitis or celiac disease was disclosed. Thus, EDS seems to be a "safe" diagnosis, and it is not unreasonable to assume that it could represent a disease entity. Although many patients had symptoms closely similar to those in duodenal ulcer, the mean basal and maximal acid output in this patient category did not differ from that observed among healthy subjects.

Entities:  

Mesh:

Year:  1987        PMID: 3611684

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

1.  Economic costs of functional dyspepsia.

Authors:  O Nyrén; G Lindberg; E Lindström; R Seensalu
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

2.  Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.

Authors:  Masahiro Sakaguchi; Miyuki Takao; Yasuo Ohyama; Hiroshi Oka; Hiroshi Yamashita; Takumi Fukuchi; Kiyoshi Ashida; Masahiro Murotani; Masuyo Murotani; Kazuo Majima; Hiroshi Morikawa; Takashi Hashimoto; Keisuke Kiyota; Hirohiko Esaki; Kanji Amemoto; Gouhei Isowa; Fumiyuki Takao
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

3.  The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies.

Authors:  N J Talley; K Lauritsen
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Small intestinal motor abnormalities in patients with functional dyspepsia demonstrated by ambulatory manometry.

Authors:  H J Jebbink; G P vanBerge-Henegouwen; L M Akkermans; A J Smout
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

Review 5.  Prevalence of dyspepsia: the epidemiology of overlapping symptoms.

Authors:  S L Grainger; H J Klass; M O Rake; J G Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

6.  A database on dyspepsia.

Authors:  G P Crean; R J Holden; R P Knill-Jones; A D Beattie; W B James; F M Marjoribanks; D J Spiegelhalter
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

7.  Dyspepsia: is a trial of therapy appropriate?

Authors:  W G Thompson
Journal:  CMAJ       Date:  1995-08-01       Impact factor: 8.262

8.  Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.

Authors:  Andrew Seng Boon Chua; P W N Keeling; T G Dinan
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 9.  A rational approach to uninvestigated dyspepsia in primary care: review of the literature.

Authors:  N L A Arents; J C Thijs; J H Kleibeuker
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

10.  Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study.

Authors:  Hye-Kyung Jung; Kwang Jae Lee; Myung-Gyu Choi; Hyojin Park; Joon Seong Lee; Poong-Lyul Rhee; Nayoung Kim; KyungSik Park; Suck Chei Choi; Oh Young Lee; Kyu Chan Huh; Geun Am Song; Su Jin Hong; Chong Il Sohn; Hwoon-Yong Jung; Yong Chan Lee; Jong Sun Rew; Sam Ryong Jee; Joong Goo Kwon
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.